Furthermore, the abnormal overexpression of APE1 promotes the secretion of TGF-β, initiating epithelial-mesenchymal transition in tumor cells and reducing the cytotoxic response of cells to drugs, resulting in poor prognosis for cancer patients [14]. Here, APEX1 is linked to neoplasm.